RecallWatchUSA

Home / Recalls / Other

NumbSkin Pain Relief Cream Recalled by SeeNext Venture Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

Recalled March 18, 2020 · CPSC recall 20724 · NumbSkin

Recalled NumbSkin pain relief cream
Hazard
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
Remedy
Replace
Units
About 8,000
Incidents / injuries
None reported.

Description

This recall involves NumbSkin pain relief cream with 5% lidocaine. The topical anesthetic cream was sold in 30 grams in a white with blue tube. NumbSkin is printed on the tube. Lot 9238 and a date code of 10/2019 through 09/2020 in a MM/YYYY format is embossed on the tub's thin end. Batch number 9238 is printed on the product packaging.

What to do

Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly.

Contact

SeeNext Venture toll-free at 844-700-6862 from 9 a.m. to 6 p.m. PT Monday through Saturday, email at [email protected] or online at www.numbskin.com and click on Recall at the home page for more information.

Product
NumbSkin pain relief cream with lidocaine
Imported by
SeeNext Venture Ltd., of Blaine, Wash.
Retailers
Online at Amazon.com from October 2019 through February 2020 for about $25.
Made in
Canada

Source: U.S. Consumer Product Safety Commission. Official recall notice on cpsc.gov →

NumbSkin Pain Relief Cream Recalled by SeeNext Venture Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert) | RecallWatchUSA